Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W. Sellers
Inhibition of Hsp90 Down-Regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel
Cancer Research
Cancer Research
Oncology
Related publications
Cytosolic PKM2 Stabilizes Mutant EGFR Protein Expression Through Regulating HSP90-EGFR Association
Oncogene
Cancer Research
Genetics
Molecular Biology
EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumours to TopoII Inhibitors
Nature
Multidisciplinary
BRAF; Epidermal Growth Factor Receptor (EGFR)
Science-Business eXchange
Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Association With HSP90 Inhibits CBL-Mediated Down-Regulation of Mutant Epidermal Growth Factor Receptors
Cancer Research
Cancer Research
Oncology
Correction To: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined With Chemotherapy Delay Brain Metastasis in Patients With EGFR‑Mutant Lung Adenocarcinoma
Targeted Oncology
Cancer Research
Oncology
Pharmacology
Mutant Epidermal Growth Factor Receptor in Benign, Borderline, and Malignant Ovarian Tumors
Clinical Cancer Research
Cancer Research
Oncology
UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-Ubiquitination Promotes EGFR Degradation
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
OA14 Phase 2 Study: Tepotinib + Gefitinib in MET+/Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
